TMEM165 Knockout cell line(Hela)

location： Home > Products > KO Cell Lines > TMEM165 Knockout cell line(Hela)

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Ocular, Otolaryngologic and Oral System

Skeleton, Articulus, Soft Tissue, Derma System

Cell Monoclonal Culture Medium

Monoclone Genotype Validation Kit

TMEM165 Knockout cell line(Hela) Order

Catalog#：YKO-H572

Price (USD)：-

Size： 1*10^6

Instruction：

Exclusive Red Cotton system（en.rc-crispr.com）was used to design the sgRNA fragment knockout strategy. Two sgRNAs were constructed into CRISPR-U™ plasmid which will be subsequentially transfected into cells by electroporation/virus method. And the single-cell clones were isolated by the limited dilution method and the Monoclone Genotype Validation Kit (Cat: YK-MV-1000) was used for cell lysis and PCR amplification on the single-cell clones, and then the genotype was verified by Sanger sequencing. Upon passing the final validation, the positive clones were expanded and cryopreserved.

Detailed Product Information Recommended Companion Products

Cell Info

Catalog	YKO-H572
Cell line	TMEM165 Knockout cell line(Hela)	Cell Type	Human Cervical Carcinoma Cell Line
Morphology	Epithelial-like, adherent	Passage ratio	1:3~1:6
Culture method	90%DMEM+10% FBS
Cryopreservation solution	50%DMEM+40% FBS+10%DMSO
Special Note

STR Validation

Gene Information

Official symbol

TMEM165

Gene id

55858

Official full symbol

transmembrane protein 165

Also known as

CDG2K, FT27, GDT1, SLC64A1, TMPT27, TPARL

This gene encodes a predicted transmembrane protein with a perinuclear Golgi-like distribution in fibroblasts. Mutations in this gene are associated with the autosomal recessive disorder congenital disorder of glycosylation, type IIk. Knockdown of this gene's expression causes decreased sialylation in HEK cells and suggests this gene plays a role in terminal Golgi glycosylation. Alternative splicing results in multiple transcript variants.